Green environments linked to lower depression and anxiety risk, study finds

FHS
March 31, 2024
11:39 pm

Comprehensive study found that prolonged exposure to green environments is associated with a reduced risk of developing depression and anxiety, suggesting air pollution as a significant pathway for this protective effect.

MindBio Therapeutics Corp. Begins Phase 2B Take-Home Microdosing Clinical Trial in Patients with Major Depressive Disorder | Psychedelic Invest

MindBio Therapeutics Corp. announced first dosing has begun in a Phase 2B randomised controlled clinical trial microdosing MB22001 in patients with Major Depressive Disorder. In

March 20, 2024

Radiopharmaceuticals startup RayzeBio submits IPO pitch, foreshadowing expected post-Labor Day bump in biotech listings

A Phase III-stage radiopharmaceuticals biotech has filed to go public a little over a week before bankers and industry watchers expect a slight post-Labor Day

August 26, 2023

Scientists discover novel compound to combat age-related blindness

Rensselaer Polytechnic Institute’s Christopher Cioffi, Ph.D., Thomas and Constance D’Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.